TFF Pharmaceuticals | 8-K: TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
TFF Pharmaceuticals | 10-Q: Quarterly report
TFF Pharmaceuticals | 8-K: Current report
TFF Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Weisman Harlan F
TFF Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lee Catherine Chai-zon
TFF Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILLS ROBERT S
TFF Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Roberts Brandi
TFF Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer COLEMAN KIRK ALLEN
TFF Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mikhak Zamaneh
TFF Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ROCAMBOLI STEPHEN
TFF Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director KING THOMAS BRAXTON
TFF Pharmaceuticals | 8-K: Current report
TFF Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
TFF Pharmaceuticals | 8-K: Current report
TFF Pharmaceuticals | 8-K: Current report
TFF Pharmaceuticals | 424B5: Prospectus
TFF Pharmaceuticals | 8-K: TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
TFF Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
TFF Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
TFF Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Double Black Diamond Offshore Ltd.(9.12%),Carlson Capital, L.P.(9.12%), etc.
No Data